| Application no. and date | 14867191.0 (espacenet) (Federated) (European Patent Register), 20141204 | | Patent/reg. no. and date | DK/EP 3076971, 20211020 | | Publication date | 20161012 | | Priority no. and date | US 201361913216 P, 20131206, US 201361914938 P, 20131211, US 201461984580 P, 20140425, US 201414322810, 20140702 | | EP pub. no. and date |
EP 3076971 20161012 | | Effective date | | | Applicant/owner | Nalpropion Pharmaceuticals LLC, 155 Franklin Rd, Suite 450
Brentwood, TN 37027, US | | Applicant ref. no. | P78918DK01 | | Inventor | KLASSEN, Preston, 7762 Lookout Drive
La Jolla, CA 92037, US,
TAYLOR, Kristin, 15023 Palomino Mesa Road
San Diego, CA 92127, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/137 (2006.01) , A61K 31/485 (2006.01) , A61P 9/10 (2006.01) | | Title | Sammensætninger og fremgangsmåder til at mindske alvorlige uønskede hjerte-kar-hændelser | | Int. application no. | US2014068527 | | Int. publication no. | WO2015085044 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
